Drug Channels Archive for August, 2022

Click a link below to view the mailing archive as if it had been sent to you.

2022-08-26 07:46Drug Channels - Your Brand Just Got Added to a Must-Have Formulary: Now What?
2022-08-23 07:46Drug Channels News Roundup, August 2022: Gov. Dean vs. Maximizers, Cancer vs. Copays, Specialty Drug Trends, Biosimilar Transitivity, and Dr. G. vs. PBMs
2022-08-22 07:46Drug Channels - Informa Connect's Copay, Reimbursement and Access Congress
2022-08-19 07:46Drug Channels - The Next Great Healthcare Surge: A 'Diagnosis Explosion'
2022-08-15 17:46Drug Channels - The 340B Program Climbed to $44 Billion in 2021—With Hospitals Grabbing Most of the Money
2022-08-12 07:46Drug Channels - Improving Out-of-Pocket Cost Transparency For Physicians
2022-08-09 07:46Drug Channels - Texas Shows Us Where PBMs' Rebates Go
2022-08-05 07:46Drug Channels - Three Technology Tactics for Overcoming Prior Authorization Hurdles
2022-08-02 07:54Drug Channels - The Shady Business of Specialty Carve-Outs


<< Archive IndexSubscribe >>